Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Ahmad R, Frishman WH, Aronow WS, et. al. "Arrhythmias in Pregnancy: A Comprehensive Review." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001031
- Tran HH, Thu A, Twayana AR, et. al. "Artificial Intelligence in Cardiac Electrophysiology: Enhancing Mapping and Ablation Precision." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001032
- Passey S, Jha J, Chanda A, et. al. "Advances in RNA-Based Therapies Targeted at Lipoprotein(a): Olpasiran in the Management of Atherosclerotic Cardiovascular Disease." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001017
- Frishman WH, Aronow WS, Alpert JS, et. al. "A combination drug pill used for first line therapy of systemic hypertension." The American journal of medicine, (), (2025) . pii: S0002-9343(25)00478-4. doi: 10.1016/j.amjmed.2025.07.021
- Szinte JS, Parikh MA, Frishman WH, et. al. "Cardiac Cachexia: A Comprehensive Review." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001008
- Tomy N, Shwartzman B, Frishman WH, et. al. "The Potential of Using Glucagon-Like Peptide-1 Receptor Agonists in Sepsis." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000998
- Mohammadi A, Jones DT, Mohammadi S, et. al. "Telomere Dynamics in Cardiovascular Aging: From Molecular Mechanisms to Precision Medicine." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001018
